Sue joins PharmaVentures as a new member of the Advisory Board based in Australia. Bringing many years of Director-level experience in biotechnology, pharmaceuticals and commercialisation. Sue joined the pharmaceutical industry with Schering Plough, then went on to work with Amgen and BMS in medical, marketing, sales management and business development roles. From 2004 to 2006, Sue was the CEO of investment and management company EQiTX Ltd. She was then CEO of RNAi therapeutics publicly listed company Benitec Ltd, including its US and UK subsidiaries.
Sue is also active on government and academic advisory committees, including being a member of the Genomics Health Futures Expert Advisory Committee (MRFF), CSIRO Health and Biosecurity Advisory Committee and Australian Advisory Board Technology and Healthcare Competitiveness - Healthcare Committee.
Sue graduated with a BPharm from the University of Queensland. She has completed a Masters of Marketing at the University of Melbourne (Melbourne Business School), a Masters of Law degree (Deakin University) and is a Fellow of the Australian Academy of Technology & Engineering Fellowship, ACPP and is a Fellow/Graduate of AICD.